Медицинская библиотека · Irish journal of medical science · 2007

Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.

Lahiff C, Khiaron O B, Nolan N, Chadwick G A

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pneumocystis carinii pneumonia (PCP) is a rare form of pneumonia associated with immune-suppression. It is common in patients with AIDS and with a CD4 count of less than 200 cells/mm(3). We report a case of PCP secondary to immune-suppression in a 41-year-old man with psoriatic arthritis being treated with the immune-modulatory agent etanercept.

METHODS

Diagnosis of PCP was made histologically using tissue obtained via transbronchial biopsy.

RESULTS

There was a good response to standard treatment with high-dose co-trimoxazole.

CONCLUSION

This report highlights a recognised but previously unreported complication of etanercept.

Для цитирования: Lahiff C, Khiaron O B, Nolan N, Chadwick G A. Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.. Irish journal of medical science. 2007. DOI: 10.1007/s11845-007-0087-x.

Предметные рубрики MeSH

Adult Arthritis, Psoriatic Biopsy, Needle Etanercept Follow-Up Studies Humans Immunoglobulin G Immunohistochemistry Immunosuppression Therapy Immunosuppressive Agents Male Pneumonia, Pneumocystis Receptors, Tumor Necrosis Factor Risk Assessment Severity of Illness Index Treatment Outcome Trimethoprim, Sulfamethoxazole Drug Combination

Подготовка и перевод публикации

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.